Recursion Pharmaceuticals RXRX
NASDAQ RXRX
$3.64 +0.03 (+0.83%)
As of: Oct 20, 2026 · 2:22 PM EDT

Recursion Pharmaceuticals (RXRX) Divestments (2025)

Updated

Recursion Pharmaceuticals' Divestments was -$4.44 million in FY2025.

Analysis

Recursion Pharmaceuticals (RXRX) Divestments (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Eli Lilly 1,149.93 Bn 1,118.52 Bn 19.71 Bn -
2 Johnson & Johnson 625.23 Bn 543.75 Bn 17.26 Bn -
3 AbbVie 512.30 Bn 485.41 Bn 12.70 Bn -
4 Merck 366.20 Bn 320.58 Bn 12.21 Bn -
5 Novartis Ag 297.82 Bn 261.81 Bn 11.24 Bn 62.00 Mn
6 Astrazeneca 261.56 Bn 235.25 Bn 12.86 Bn -
7 Amgen 235.12 Bn 190.52 Bn 7.24 Bn -
8 Gilead Sciences 194.40 Bn 168.60 Bn 6.22 Bn -
9 Pfizer 172.31 Bn 118.96 Bn 10.94 Bn -
10 Recursion Pharmaceuticals 1.94 Bn -665.13 Mn -3.82 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -4.44 Mn
API Access

Recursion Pharmaceuticals Divestments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=divestments&ticker=RXRX&period=max&api_key=YOUR_API_KEY